Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut Allergy
- 25 October 2010
- journal article
- research article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 154 (4), 318-327
- https://doi.org/10.1159/000321824
Abstract
Rationale: Basophils contribute to anaphylaxis and allergies. We examined the utility of assessing basophil-associated surface antigens (CD11b/CD63/CD123/CD203c/CD294) in characterizing and monitoring subjects with nut allergy. Methods: We used flow cytometry to analyze basophils at baseline (without any activation) and after ex vivo stimulation of whole blood by addition of nut or other allergens for 2, 10, and 30 min. We also evaluated whether basophil expression of CD11b/CD63/CD123/CD203c/CD294 was altered in subjects treated with anti-IgE monoclonal antibody (omalizumab) to reduce plasma levels of IgE. Results: We demonstrate that basophil CD203c levels are increased at baseline in subjects with nut allergy compared to healthy controls (13 subjects in each group, p < 0.0001). Furthermore, we confirm that significantly increased expression of CD203c occurs on subject basophils when stimulated with the allergen to which the subject is sensitive and can be detected rapidly (10 min of stimulation, n = 11, p < 0.0008). In 5 subjects with severe peanut allergy, basophil CD203c expression following stimulation with peanut allergen was significantly decreased (p < 0.05) after 4 and 8 weeks of omalizumab treatment but returned toward pretreatment levels after treatment cessation. Conclusions: Subjects with nut allergy show an increase of basophil CD203c levels at baseline and following rapid ex vivo stimulation with nut allergen. Both can be reduced by omalizumab therapy. These results highlight the potential of using basophil CD203c levels for baseline diagnosis and therapeutic monitoring in subjects with nut allergy.Keywords
This publication has 41 references indexed in Scilit:
- Practical allergy (PRACTALL) report: risk assessment in anaphylaxisAllergy, 2007
- Modern Flow Cytometry: A Practical ApproachClinics In Laboratory Medicine, 2007
- Flow cytometry for basophil activation markers: The measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergyJournal of Immunological Methods, 2007
- Diagnostic Tests Based on Human Basophils: Potentials, Pitfalls and PerspectivesInternational Archives of Allergy and Immunology, 2006
- Chronic urticaria sera increase basophil CD203c expressionJournal of Allergy and Clinical Immunology, 2006
- 9. Food allergyJournal of Allergy and Clinical Immunology, 2006
- Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapyJournal of Immunological Methods, 2005
- FACS innovation: a view from Stanford.2004
- Analysis of cytokine signaling in patients with extrinsic asthma and hyperimmunoglobulin EJournal of Allergy and Clinical Immunology, 1998
- Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.The Journal of Immunology, 1997